customizing contrast injection for body mdct: algorithmic … · 2013-12-09 · contrast volume 98...
TRANSCRIPT
Customizing Contrast Injection for Body MDCT:
Algorithmic Approach
Customizing Contrast Injection for Body MDCT:
Algorithmic Approach
Lincoln L. Berland, M.D., F.A.C.R.Lincoln L. Berland, M.D., F.A.C.R.Lincoln L. Berland, M.D., F.A.C.R.
University of Alabamaat Birmingham
University of AlabamaUniversity of Alabamaatat BirminghamBirmingham
Before Contrast
Prep and Hydration
• Hydration single most important factor:To get adequate collecting system fillingTo limit nephrotoxicity
• Don't keep patient NPO (clear liquids in am)• Lots of water prior to scan
Intravenous Contrast Parameters
• Contrast or not?• Route - IV arm, central line, hand, foot• Concentration• Volume• Rate• Saline chaser• Fixed, bolus tracking, test bolus
Principles of Intravenous Contrast Dynamics
General - Iodine Dose
• If increase dose of Iodine, but inject within same duration:
Increases peak enhancementDoes not change time at which peak occurs
• How to achieve this:Increase contrast concentration, orIncrease injection rate, maintain injection duration (more contrast volume)
Iodine Concentration Selection
• Higher concentration: can inject more Iodine for a specific volume/second
Equivalent to increasing injection rate if you don’t increase concentration
• With higher concentration, can decrease the volume injection rate for given Iodineinjection rate
• Therefore, 350-400 mg I/mL preferred over 300 mg I/mL
Aorta, Liver by Rate
• If increase injection rate, but keep Iodine dose constant:
Aortic enhancement peak increases continuously with rateLiver enhancement peak levels off above 1.5 mL/sec
Aorta, Liver Enhancement
• MYTH:Can decrease contrast dose for liver scan by increasing injection rate
• TRUTH:Can decrease contrast dose for CTA by increasing injection rate
Injection Duration
• TIME to peak aortic and liver enhancement depends most strongly on injection duration
• Peak enhancement usually occurs shortly after injection completed
Injection Duration
• MYTH:For body scans, can use fixed scan delay regardless of injection rate
• TRUTH:Enhancement curves vary greatly by patientUse bolus tracking for arterial studiesFixed delay (by duration) usually OK for liver,etc.
Scan Delay
• MYTH: Faster scanner (e.g. 64 vs. 4-slice), shorter delay to scanning
• TRUTH: Faster scanner, longer delay to begin scanning
Peak doesn’t change, but more likely to finish scan before peak occursDownslope of enhancement not as fast as upslope, so better to scan a little late rather than early
Patient-Specific Factors
Patient Weight - Enhancement
• Hepatic and arterial enhancement are proportional to Iodine dose administered and inversely proportional to weight
• Time to the enhancement peak is affected little by weight
• Therefore, Iodine dose should be increased proportional to weight
Cardiac Output - Aorta
• As cardiac output decreases, delay to peak increases
• MYTH: As cardiac output decreases, enhancement decreases
• TRUTH: Decreased cardiac output increases enhancement
• Therefore, decrease Iodine dose with decreased cardiac function
Cardiac Output - Hepatic
• As cardiac output decreases, delay to hepatic enhancement increases
60% decrease in cardiac output can delay peak from baseline 60 seconds to 150 seconds
• MYTH: Decreased cardiac output affects peak hepatic enhancement
• TRUTH: Hepatic enhancement won’t change, but later peak
Phase by Application
• Consequence of these effects is that you must consider the target organ(s) to best design protocols, e.g.:
Earlier scan for aortaSlower scan for runoffLater scan for liver
Contrast - From Theory to Practice
Iodine Dose Selection
• Patient weight• Renal and cardiac function• Brand and concentration of
contrast available• Organ and body region
Iodine Dose Selection
• Base dose varies from 30-60 gm Iodine• Should select based on Iodine dose, not
volume• We recommend standard dose based of
42 gm Iodine for average weight patient• Select by patient weight, other factors
Iodine Dose Selection
• Some select: mL/kg• If vary continuously by weight:
Should be: gm I/kg• We prefer weight categories for
the average patient
Contrast Injection Rate Selection
• Route of injection• Adequacy of line• Injector - Dual Head with saline
chaser better uses contrast injected• Speed of scanner
Scan Timing Selection
• Specific application (e.g. 3-phase, routine, etc.)
• Speed of scanner
Algorithm
• Weight +concentration of agent + application:Volume
• Volume + application + adequacy of IV:Injection rate
• Injection rate + volume:Injection duration
• Injection duration + application + scanner:Scan timing
Contrast Dose Selection
Contrast Volume85 mL
120 mL150 mL180 mL
Contrast Volume56 mL80 mL
100 mL
45-60 kg (100-130 lb)
Select Contrast DoseBody CT
Based on 42 gI for average patient
350 mg/mLWeight
65-90 kg (140-200 lbs)90-110 kg (200-240 lb)
>110 kg (>240 lb)
>90 kg (>200 lb)65-90 kg (140-200 lbs)45-60 kg (100-130 lb)
350 mg/mL Š Renal insufficiencyWeight
Contrast Volume85 mL115 mL140 mL175 mL
Contrast Volume55 mL75 mL90 mL
90-110 kg (200-240 lb)>110 kg (>240 lb)
>90 kg (>200 lb)65-90 kg (140-200 lbs)45-60 kg (100-130 lb)
370 mg/mL Š Renal insufficiencyWeight
Body CT
Based on 42 gI for average patient
370 mg/mL
60-90 kg (130-200 lbs)
Weight45-60 kg (100-130 lb)
Select Contrast Dose
Contrast Dose Selection
Contrast Volume104 mL148 mL185 mL200 mL*
Contrast Volume56 mL80 mL
100 mL
350 mg/mL Š Renal insufficiencyWeight
Select Contrast DoseBody CT
Based on 52 gI for average patient
350 mg/mL
Notes:
Weight45-60 kg (100-130 lb)65-90 kg (140-200 lbs)90-110 kg (200-240 lb)
>110 kg (>240 lb)
>90 kg (>200 lb)65-90 kg (140-200 lbs)45-60 kg (100-130 lb)
*Calculated volume for high weight exceeds 200 mL capacity of injector.Renal insufficiency dose based on 42 gI chart rather than 52 gI chart.
Contrast Volume98 mL
140 mL175 mL200 mL*
Contrast Volume55 mL75 mL90 mL
Weight
Body CT
Based on 52 gI for average patient
370 mg/mLWeight
45-60 kg (100-130 lb)
Select Contrast Dose
Notes:*Calculated volume for high weight exceeds 200 mL capacity of injector.Renal insufficiency dose based on 42 gI chart rather than 52 gI chart.
60-90 kg (130-200 lbs)90-110 kg (200-240 lb)
>110 kg (>240 lb)
>90 kg (>200 lb)65-90 kg (140-200 lbs)45-60 kg (100-130 lb)
370 mg/mL Š Renal insufficiency
Contrast Injection Rate
Injection Volume Injection Rate Injection Duration46-50 mL 1.6 mL/sec 30 seconds51-55 mL 1.8 mL/sec 30 seconds56-60 mL 2.0 mL/sec 30 seconds61-65 mL 2.1 mL/sec 30 seconds66-70 mL 2.3 mL/sec 30 seconds71-75 mL 2.5 mL/sec 30 seconds76-80 mL 2.6 mL/sec 30 seconds81-85 mL 2.8 mL/sec 30 seconds86-90 mL 3.0 mL/sec 30 seconds91-95 mL 3.1 mL/sec 30 seconds96-100 mL 3.3 mL/sec 30 seconds101-105 mL 3.5 mL/sec 30 seconds106-110 mL 3.6 mL/sec 30 seconds111-115 mL 3.8 mL/sec 30 seconds116-120 mL 4.0 mL/sec 35 seconds136-140 mL 4.6 mL/sec 30 seconds141-145 mL 4.8 mL/sec 30 seconds146-150mL 5.0 mL/sec 30 seconds
175 mL 5.8 mL/sec 30 seconds180 mL 6.0 mL/sec 30 seconds185 mL 6.0 mL/sec 31 seconds200 mL 6.0 mL/sec 33 seconds
Body CT (excluding CTAs)
All contrast agents
Routine injection duration
Select Injection Rate
Contrast Injection Rate
Injection Volume Injection Rate Injection Duration46-50 mL 1.6 mL/sec 30 seconds51-55 mL 1.8 mL/sec 30 seconds56-60 mL 2.0 mL/sec 30 seconds61-65 mL 2.0 mL/sec 32 seconds66-70 mL 2.0 mL/sec 35 seconds71-75 mL 2.0 mL/sec 37 seconds76-80 mL 2.0 mL/sec 40 seconds81-85 mL 2.0 mL/sec 42 seconds86-90 mL 2.0 mL/sec 45 seconds91-95 mL 2.0 mL/sec 47 seconds96-100 mL 2.0 mL/sec 50 seconds101-105 mL 2.0 mL/sec 52 seconds106-110 mL 2.0 mL/sec 55 seconds111-115 mL 2.0 mL/sec 57 seconds116-120 mL 2.0 mL/sec 60 seconds136-140 mL 2.0 mL/sec 70 seconds141-145 mL 2.0 mL/sec 72 seconds146-150mL 2.0 mL/sec 75 seconds
175 mL 2.0 mL/sec 87 seconds180 mL 2.0 mL/sec 90 seconds185 mL 2.0 mL/sec 92 seconds200 mL 2.0 mL/sec 100 seconds
If IV cannot accept > 2.0 mL/sec
Body CT (excluding CTAs)
All contrast agents
Select Injection Rate
Delay70 seconds71 seconds72 seconds73 seconds75 seconds77 seconds80 seconds82 seconds85 seconds87 seconds90 seconds92 seconds95 seconds97 seconds100 seconds110 seconds112 seconds115 seconds127 seconds130 seconds131 seconds140 seconds
Routine Scans
All delays from the beginning of injection
31 seconds32 seconds
60 seconds
90 seconds
70 seconds72 seconds75 seconds87 seconds
37 seconds
100 seconds92 seconds
Body CT (excluding CTAs)
All scanners
Portal phase routine scan
Select Scanning Delay
Injection Duration30 seconds
57 seconds
33 seconds35 seconds
40 seconds42 seconds45 seconds
55 seconds52 seconds50 seconds47 seconds
Implementing Algorithm
• Loose leaf handbooks (cookbooks) created• One customized cookbook placed at each
scanner• Each cookbook is specific for scanner type
and concentration of contrast material used• Master reference cookbooks placed in
radiology reading room
Indications:Cirrhosis: evaluating for HCC and portal hypertension.Pre-Intervention planning: for TIPS, chemoembolization, embolization, ablation.Cholangiocarcinoma.Characterize unknown liver lesion.Notes, modifications:Should be done on 40 or 64-slice scanners, if possible, because 3D rendering is usually needed and these provide better image qualityPelvis should be performed if concern about pelvic metastasis or if known prior important pelvic abnormalityIf following up vascular metastases that are known to be seen best on portal venous phase, perform routine abdomen protocol.
Contrast Unenhanced Phase (UP)Hepatic Arterial Phase
(HAP)Portal Venous Phase (PVP) Delayed Phase (DP) Comments
Oral contrast No NoRectal contrast No NoIV contrast Š iodine conc. (mgI/mL) 350-370
Iodine dose (gI), Volume and Flow Rate
52 gI for 60-90 kg patient. Adjust proportionally for weight. See
"Contrast Cookbook"This is a higher dose than routine protocols to optimize post-
processing and segmentationSaline flush - volume (mL) 50 If no dual injector, increase contrast dose by 10 mLSaline flush - flow rate (mL/s) Same as contrast injection rate
Scan delayTrigger at 150 HU in aorta plus 15
seconds 45 seconds post-trigger 3 minutes post-triggerHAP slightly later than routine AP. Change delay to 10 minute for
cholangiocarcinomaAcquisition Parameters
Scout PALateral scanogram can help see spinal compressions; post-scan
scanogram serves as a one-shot IVPPatient position Supine, feet first Supine, feet first Supine, feet first Supine, feet first
Scan range Diaphragm to iliac crest Diaphragm to iliac crestDiaphragm to iliac crest or
greater trochanter LiverScanning direction Out Out Out OutAcquisition field of view Full patient width Full patient width Full patient width Full patient widthTube voltage (kVp) 120 120 120 120 Can use 140 kVp for large patientsTube load (mAs) 170 to 200 250 to 300 250 to 300 170 to 200 Consider automated dose modulationGantry rotation time (s) 0.5 0.5 0.5 0.5 Consider 0.75 for obese patients
Detector configuration (mm) 40 x 0.625 or 64 x 0.625 40 x 0.625 or 64 x 0.62540 x 0.625 or 64 x
0.62532 x 1.25 or 64 x 0.625
Pitch 1 1 1 1Scanner automatically assigns optimal pitch based on approximate
selection.Reconstruction ParametersAxial reconstruction (mm) 5.0 x 5.0 5.0 x 5.0 5.0 x 5.0 5.0 x 5.0Thin section axial for 3D/MPR (mm) 1.3 x 0.7 up to 2.0 x 1.0 1.3 x 0.7 up to 2.0 x 1.0
Coronal reconstruction (mm) 3.0 Š 4.0 x 3.0 3.0 Š 4.0 x 3.0
Coronal and sagittal reconstructions should be performed routinely on HAP and PVP. Thick slab MIPs and/or sagittal MIPs may
replace coronal and sagittal MPRs.
Recon filter kernel B or C B or C B or C
Filter A helpful for very obese patients (less noisy images). Filter B if lower mAs chosen (more noise than Filter A, but appropriate for
average patient). Filter C increases spatial resolution, but also increases noise.
Recon field of view Evolving Evolving Evolving
Liver Four-Phase (Abdomen or Abdomen/Pelvis): 40-slice, 64-slice
Indications:Pancreatic mass known or suspected.Pancreatic carcinoma follow-up after treatment (surgery, XRT, chemotherapy) if pancreatic phase needed (see Exclusions, Notes below).Painless jaundice.Chronic pancreatitis vs. pancreatic mass.Acute pancreatitis > age 50 to rule out mass as etiology of pancreatitis.Exclusions:Acute pancreatitis < age 50 (Routine protocol).Known chronic pancreatitis to evaluate complications (Routine protocol).Known pancreatic adenocarcinoma recurrence or metastasis if well seen on PVP (Routine protocol).Pancreatic neuroendocrine tumor follow-up after treatment (RCC, Vascular Cancer FU protocol).Notes, modifications:Should be done on 40 or 64-slice scanners, if possible, because 3D rendering is usually needed and these provide better image quality.Pelvis should be performed if concern about pelvic metastasis or if known prior important pelvic abnormality.If following known unresectable pancreatic carcinoma, including with metastases, a routine abdomen or abdomen/pelvis may suffice.Routine examination may also be done for chronic pancreatitis to evaluate complications, acute pancreatitis < age 50, or pancreatitis reassessment.Contrast Unenhanced Phase (UP) Pancreatic Phase (PP) Portal Venous Phase (PVP) Comments
Oral contrast
Water or VolumenTM 500 mL to tolerance plus 250 mL
water on tableRectal contrast NoIV contrast Š iodine conc. (mgI/mL) 350-370
Iodine dose (gI), Volume and Flow Rate
52 gI for 60-90 kg patient. Adjust proportionally for weight. See
"Contrast Cookbook"
This is a higher dose than routine protocols to optimize post-processing and segmentation.
Prefer higher injection rate, if possible, up to 5 mL/sec.
Saline flush - volume (mL) 30If no dual injector, increase contrast dose by 10
mLSaline flush - flow rate (mL/s) Same as contrast injection rate
Scan delayTrigger at 150 HU in aorta plus 15
seconds 50 seconds post-triggerAcquisition Parameters
Scout PA
Lateral scanogram can help see spinal compressions; post-scan scanogram serves as a
one-shot IVPPatient position Supine, feet first Supine, feet first Supine, feet first
Scan range Diaphragm to iliac crest Diaphragm to iliac crestDiaphragm to iliac crest or greater
trochanterScanning direction Out Out OutAcquisition field of view Full patient width Full patient width Full patient widthTube voltage (kVp) 120 120 120 Can use 140 kVp for large patientsTube load (mAs) 170 to 200 250 to 300 250 to 300 Consider automated dose modulationGantry rotation time (s) 0.5 0.5 0.5 Consider 0.75 for obese patients
Detector configuration (mm) 40 x 0.625 or 64 x 0.625 40 x 0.625 or 64 x 0.62540 x 0.625 or 64 x
0.625
Pitch 1 1 1Scanner automatically assigns optimal pitch
based on approximate selection.Reconstruction ParametersAxial reconstruction (mm) 5.0 x 5.0 2.0 x 2.0 4.0 x 3.0
Thin section axial for 3D/MPR (mm) 1.3 x 0.7 up to 2.0 x 1.0 1.3 x 0.7 up to 2.0 x 1.0
Perform 3D volume and curved planar reformatting. Note: qualifies for additional post-
processing coding
Coronal reconstruction (mm) 3.0 Š 4.0 x 3.0 3.0 Š 4.0 x 3.0
Coronal reconstructions should be performed on both the Pancreatic and Portal Venous phases. Thick slab MIPs and/or sagittal MIPs may be considered as a replacement for coronal and
sagittal MPRs.
Recon filter kernel B or C B or CFilter A helpful for very obese patients. Filter B if
lower mAs chosenRecon field of view Evolving Evolving
Pancreas (Abdomen or Abdomen/Pelvis): 40-slice, 64-slice
Renal Mass Pre-Intervention
Renal Mass Pre-intervention
• Indications:Prepare for nephron-sparing surgery or ablation
• Objectives:Define detailed vascular supplyLocalizationStaging
Scan Phases
• Non-contrastMay delete if have had recent non-contrast
• ArterialThrough mid-pelvis to assure ID of anomalous arteries
• Nephrographic/excretoryEntire abdomen-pelvisSplit-dose
Split-Dose Injection
• Permits multiple purposes in single series, e.g.
Late corticomedullary-early nephrographicNephrographic-excretory
Split-Dose Injection Purpose
• Combine advantages of excretory, nephrographic and portal venous phases
• Use for both renal mass pre-intervention and CT urography protocols
Renal mass includes arterial phaseCT urography does not
Split-Dose Protocol Example
• Example:115 mL Isovue 370 selected for 70 kg patientInject about 1/4 of usual dose (30 mL) by hand
• Wait 10 minutes for excretion• 300 mL saline IV during pause• Inject additional complete dose (115 mL @ 4
mL/sec)• Arterial phase• Scan delay of 100 sec (for nephrographic
phase)
Nephrographic-Excretory
Late CM-Arterial-Excretory
Split-Dose Injection
Lesion margins seen better on nephrographic phase
Renal Mass Visualization
Nephrographic/Excretory depicts vascular-collecting system to lesion relationships
Post-Processing - MIPS
Arterial-Nephrographic Nephrographic-Excretory
Split-Dose Injection
Summary
• CT technology and protocol design is extremely complex.
• First step to tailoring exams is to understand basic principles of contrast dynamics and CT technology.